Which Patients May Be Administered Tissue Plasminogen Activator Safely?

Which Patients May Be Administered Tissue Plasminogen Activator Safely? Tissue plasminogen activator (tPA) is an intravenous medicine given for ischemic stroke – a stroke caused by a blood clot – that can dissolve the stroke-causing clot. Studies show that people who receive tPA within 3 hours – up to 4.5 hours in some patients –

Which Of The Following Is The Most Common Side Effect Of Tissue Plasminogen Activator TPA )?

Which Of The Following Is The Most Common Side Effect Of Tissue Plasminogen Activator TPA )? What are the side effects of alteplase (TPA, Activase, Cathflo Activase)? The most common and serious side effect of alteplase is bleeding. Minor bleeding is more common, but significant bleeding such as into the brain (intracranial hemorrhage) or fatal